Lameck Symekah
Psychiatric/Mental Health · Garland, TXNPI 1669143525
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 627 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,866, more than ten times the $228 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 627 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Vanda Pharmaceuticals Inc.$832
- Neurocrine Biosciences, Inc.$717
- Lundbeck LLC$699
- Teva Pharmaceuticals USA, Inc.$669
- plus $4K from 22 others
What the payments were for
- Food & beverage$9,88198%
- Education$1832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 192 | $2,402 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 73 | $1,100 |
| Vanda Pharmaceuticals Inc. | 42 | $832 |
| Neurocrine Biosciences, Inc. | 35 | $717 |
| Lundbeck LLC | 35 | $699 |
| Teva Pharmaceuticals USA, Inc. | 34 | $669 |
| Otsuka America Pharmaceutical, Inc. | 45 | $646 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $539 |
| Alkermes, Inc. | 28 | $462 |
| Supernus Pharmaceuticals, Inc. | 21 | $387 |
| Axsome Therapeutics, Inc. | 14 | $294 |
| E.r. Squibb & Sons, L.L.C. | 20 | $266 |
| Almatica Pharma LLC | 13 | $243 |
| Johnson & Johnson | 10 | $227 |
| OWP Pharmaceuticals, Inc. | 5 | $100 |
| Sunovion Pharmaceuticals Inc. | 7 | $95 |
| Ironshore Pharmaceuticals Inc. | 5 | $82 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Bausch Health US, LLC | 3 | $43 |
| Merck | 2 | $36 |
| Corium, LLC | 1 | $28 |
| Tris Pharma Inc | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Indivior Inc. | 1 | $14 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$102
How this compares
$10,064 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 14 | $1,330 |
| Divalproex Sodium | 46 | $917 |
| Mirtazapine | 60 | $728 |
| Olanzapine | 39 | $671 |
| Risperidone | 54 | $468 |
| Buspirone Hcl | 70 | $433 |
| Oxcarbazepine | 19 | $430 |
| Aripiprazole | 32 | $421 |
| Hydroxyzine Hcl | 28 | $406 |
| Duloxetine Hcl | 11 | $398 |
| Quetiapine Fumarate | 45 | $380 |
| Prazosin Hcl | 25 | $365 |
| Trazodone Hcl | 83 | $322 |
| Escitalopram Oxalate | 48 | $304 |
| Lamotrigine | 40 | $271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $243 | $5412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Garland
- Eunice OntitaGarland$18K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.